spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Ambien  

 HSMN NewsFeed - 10 Jan 2013
FDA Drug Safety Communication: Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist)
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Oct 2008
Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 27 Aug 2008
BioAlliance Pharma SA appoints Pierre MORGON Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jun 2008
Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder
Biopharmaceuticals
 HSMN NewsFeed - 23 Jan 2008
NovaDel's New Drug Application for ZolpiMist(TM) Oral Spray to Treat Insomnia Accepted for Filing by the U.S. Food and Drug Administration
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 4 Jan 2008
Ambien CR(R) (zolpidem tartrate extended-release) tablets CIV Improved Chronic Insomnia in Patients with Co-Morbid Generalized Anxiety Disorder
Biopharmaceuticals
 HSMN NewsFeed - 24 Oct 2007
New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV
Biopharmaceuticals
 HSMN NewsFeed - 22 Jun 2007
TransOral Pharmaceuticals, Inc. Changes Name to Transcept Pharmaceuticals, Inc.
Biopharmaceuticals
 HSMN NewsFeed - 26 Apr 2007
Ranbaxy Receives Final Approval to Manufacture and Market Zolpidem Tablets for Insomnia
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 Apr 2007
Dr. Reddy's Announces the Launch of Zolpidem Tartrate Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 23 Apr 2007
Prasco Enters into Agreement with sanofi-aventis to Market the Authorized Generic Versions of Ambien(R) (Zolpidem Tartrate) CIV
Biopharmaceuticals Generics Distribution
 HSMN NewsFeed - 23 Apr 2007
Mylan Announces Final FDA Approval and Immediate Shipment of Zolpidem Tartrate Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 6 Apr 2007
Barr Confirms Patent Challenge of Ambien CR(R)
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 12 Jul 2006
New Data Support Long-Term Use of AMBIEN CRTM (zolpidem tartrate extended- release) Tablets C(IV) for up to 24 Weeks
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 9

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 9 additional stories matching:
Ambien
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.